Fortis’s Agilus challenge deepens
Forced to buy out investors of its struggling diagnostics arm, Fortis now has the additional burden of reviving Agilus even as it’s trying to get the core healthcare business back on track.
Subscribe to read this story
We publish over 500 original, detailed stories every year on startups, corporates, stock markets and economic current affairs.
$99 for one year
Not ready to subscribe? Sign up for a free account
We value our free readers. Read 100+ stories every year.
More in Business
You may also like
Urban Company’s growth has hit India’s income divide reality
Last valued at upwards of $2 billion, the beauty and home services business gearing up for an IPO is too small and too susceptible to market challenges. Its draft papers are worth a look.
Jupiter Life Line Hospitals takes the road less travelled
The hospital chain’s regional as well as insured patient focus has stood it in good stead so far. Its plans to expand could pose challenges though.
Can Zepto’s shift in focus before IPO be fruitful?
The quick-commerce platform has slowed down dark store expansion. Instead, it's focusing on profitability by adding more categories and going deep in existing cities.
